Polymyxin B/neomycin/hydrocortisone Otic Susp

— THERAPEUTIC CATEGORIES —
  • Ear infections (topicals)

Polymyxin B/neomycin/hydrocortisone Otic Susp Generic Name & Formulations

General Description

Polymyxin B sulfate 10000Units, neomycin sulfate 3.5mg, hydrocortisone 10mg; per mL.

Pharmacological Class

Antibiotics + steroid.

How Supplied

TC—10mL (w. dropper); Soln, Susp—contact supplier

Polymyxin B/neomycin/hydrocortisone Otic Susp Indications

Indications

Susceptible infections of external auditory canal.

Polymyxin B/neomycin/hydrocortisone Otic Susp Dosage and Administration

Adult

Clean ear. 4 drops in ear(s) 3–4 times daily; max 10 days.

Children

Clean ear. 3 drops in ear(s) 3–4 times daily; max 10 days.

Polymyxin B/neomycin/hydrocortisone Otic Susp Contraindications

Contraindications

Cutaneous viral infection in ear (eg, herpes simplex, vaccinia, varicella zoster virus).

Polymyxin B/neomycin/hydrocortisone Otic Susp Boxed Warnings

Not Applicable

Polymyxin B/neomycin/hydrocortisone Otic Susp Warnings/Precautions

Warnings/Precautions

Perforated eardrum. Chronic otitis media. Asthma (soln). Reevaluate if no improvement in 1 week. Discontinue if local irritation or sensitization occurs. Pregnancy (Cat.C). Nursing mothers.

Polymyxin B/neomycin/hydrocortisone Otic Susp Pharmacokinetics

Elimination

Renal, fecal.

Polymyxin B/neomycin/hydrocortisone Otic Susp Interactions

Not Applicable

Polymyxin B/neomycin/hydrocortisone Otic Susp Adverse Reactions

Adverse Reactions

Local reactions, contact dermatitis, oto- or nephrotoxicity in prolonged use, superinfection.

Polymyxin B/neomycin/hydrocortisone Otic Susp Clinical Trials

See Literature

Polymyxin B/neomycin/hydrocortisone Otic Susp Note

Notes

Soln and Susp formerly known under the brand names Cortisporin, Oticair, Otocort, Pediotic.

Polymyxin B/neomycin/hydrocortisone Otic Susp Patient Counseling

See Literature